Business Description
Medclair AB
ISIN : SE0009190572
Total Employee Number:
15Compare
Compare
Traded in other countries / regions
MCLR.Sweden IPO Date
2017-03-03Description
Medclair AB operates in healthcare industry. The company has two units: Central Destruction Unit (CDU) and Mobile Destruction Unit (MDU) decomposes the nitrous oxide entering the unit, transforming it to nitrogen (N2) och oxygen (O2). It also provide solutions for various N2O methods such as double mask, single mask, mouthpiece, or free flow, which ensures a safe work environment for healthcare professionals.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.89 | |||||
Interest Coverage | 9.74 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 16.78 | |||||
Beneish M-Score | -2.35 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 31 | |||||
3-Year EBITDA Growth Rate | 180.2 | |||||
3-Year Book Growth Rate | 0.6 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 79.13 | |||||
9-Day RSI | 79.59 | |||||
14-Day RSI | 76.69 | |||||
3-1 Month Momentum % | 0.85 | |||||
6-1 Month Momentum % | -15.71 | |||||
12-1 Month Momentum % | 13.46 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.85 | |||||
Quick Ratio | 4.19 | |||||
Cash Ratio | 1.97 | |||||
Days Inventory | 174.52 | |||||
Days Sales Outstanding | 26.74 | |||||
Days Payable | 86.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 71.59 | |||||
Operating Margin % | 9.05 | |||||
Net Margin % | 8.15 | |||||
EBITDA Margin % | 18.28 | |||||
FCF Margin % | -2.03 | |||||
OCF Margin % | -2.03 | |||||
ROE % | 7.5 | |||||
ROA % | 6.55 | |||||
ROIC % | 8.56 | |||||
3-Year ROIIC % | -1023.2 | |||||
ROC (Joel Greenblatt) % | 56.53 | |||||
ROCE % | 8.32 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 76.25 | |||||
PE Ratio without NRI | 76.25 | |||||
Price-to-Owner-Earnings | 64.44 | |||||
PS Ratio | 4.71 | |||||
PB Ratio | 3.53 | |||||
Price-to-Tangible-Book | 6.22 | |||||
Price-to-Free-Cash-Flow | 762.5 | |||||
Price-to-Operating-Cash-Flow | 762.5 | |||||
EV-to-EBIT | 56.22 | |||||
EV-to-EBITDA | 27.85 | |||||
EV-to-Revenue | 5.09 | |||||
EV-to-FCF | -238.74 | |||||
Price-to-GF-Value | 1.3 | |||||
Price-to-Projected-FCF | 6.78 | |||||
Price-to-Graham-Number | 4.55 | |||||
| Price-to-Net-Current-Asset-Value | 7.09 | |||||
| Price-to-Net-Cash | 27.73 | |||||
Earnings Yield (Greenblatt) % | 1.78 | |||||
FCF Yield % | -0.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medclair AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 54.69 | ||
| EPS (TTM) (kr) | 0.04 | ||
| Beta | 0.3734 | ||
| 3-Year Sharpe Ratio | 0.61 | ||
| 3-Year Sortino Ratio | 1.3 | ||
| Volatility % | 44.19 | ||
| 14-Day RSI | 76.69 | ||
| 14-Day ATR (kr) | 0.155728 | ||
| 20-Day SMA (kr) | 2.5525 | ||
| 12-1 Month Momentum % | 13.46 | ||
| 52-Week Range (kr) | 1.865 - 3.4 | ||
| Shares Outstanding (Mil) | 91.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medclair AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medclair AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-05 | In 113 days | ||
| Second quarter earnings results for 2026 | 2026-08-20 | In 36 days | ||
| First quarter earnings results for 2026 | 2026-05-07 | 2.35 (+2.17%) | ||
| General meeting for 2026 | 2026-04-22 13:00 | 2.35 (-1.26%) | ||
| Annual report for 2025 | 2026-04-01 | 2.34 (+6.36%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-18 | 2.85 (+4.01%) | ||
| Third quarter earnings results for 2025 | 2025-11-06 | 3.02 (+2.03%) | ||
| Second quarter earnings results for 2025 | 2025-08-21 | 2.69 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-05-08 | 1.58 (+3.28%) | ||
| General meeting for 2025 | 2025-04-16 13:00 | 1.54 (+0.00%) |
Show
Entries
Medclair AB Frequently Asked Questions
What is Medclair AB(NGM:MCLR)'s stock price today?
The current price of NGM:MCLR is kr3.05. The 52 week high of NGM:MCLR is kr3.40 and 52 week low is kr1.87.
When is next earnings date of Medclair AB(NGM:MCLR)?
The next earnings date of Medclair AB(NGM:MCLR) is 2026-08-20.
Does Medclair AB(NGM:MCLR) pay dividends? If so, how much?
Medclair AB(NGM:MCLR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Medclair AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers